Cargando…

Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()

BACKGROUND: The coronavirus disease 2019 (COVID-19) has been a fast-growing worldwide pandemic. AIMS: We aimed to investigate the incidence of cardiac arrhythmias among a large French cohort of implantable cardioverter defibrillator recipients over the first 5 months of 2020. METHODS: Five thousand...

Descripción completa

Detalles Bibliográficos
Autores principales: Galand, Vincent, Hwang, Elliot, Gandjbakhch, Estelle, Sebag, Frédéric, Marijon, Eloi, Boveda, Serge, Leclercq, Christophe, Defaye, Pascal, Rosier, Arnaud, Martins, Raphaël Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141722/
https://www.ncbi.nlm.nih.gov/pubmed/34088625
http://dx.doi.org/10.1016/j.acvd.2021.02.005
_version_ 1783696424444100608
author Galand, Vincent
Hwang, Elliot
Gandjbakhch, Estelle
Sebag, Frédéric
Marijon, Eloi
Boveda, Serge
Leclercq, Christophe
Defaye, Pascal
Rosier, Arnaud
Martins, Raphaël Pedro
author_facet Galand, Vincent
Hwang, Elliot
Gandjbakhch, Estelle
Sebag, Frédéric
Marijon, Eloi
Boveda, Serge
Leclercq, Christophe
Defaye, Pascal
Rosier, Arnaud
Martins, Raphaël Pedro
author_sort Galand, Vincent
collection PubMed
description BACKGROUND: The coronavirus disease 2019 (COVID-19) has been a fast-growing worldwide pandemic. AIMS: We aimed to investigate the incidence of cardiac arrhythmias among a large French cohort of implantable cardioverter defibrillator recipients over the first 5 months of 2020. METHODS: Five thousand nine hundred and fifty-four implantable cardioverter defibrillator recipients were followed by remote monitoring during the COVID-19 period (from 01 January to 31 May 2020). Data were obtained from automated remote follow-up of implantable cardioverter defibrillators utilizing the Implicity® platform. For all patients, the type of arrhythmia (atrial fibrillation, ventricular tachycardia or ventricular fibrillation), the number of ventricular arrhythmia episodes and the type of implantable cardioverter defibrillator-delivered therapy were recorded. RESULTS: A total of 472 (7.9%) patients presented 4917 ventricular arrhythmia events. An increase in ventricular arrhythmia incidence was observed after the first COVID-19 case in France, and especially during weeks #10 and #11, at the time of major governmental measures, with an increase in the incidence of antitachycardia pacing delivered therapy. During the 11 weeks before the lockdown order, the curve of the percentage of live-stream television coverage of COVID-19 information matched the ventricular arrhythmia incidence. During the lockdown, the incidence of ventricular arrhythmia decreased significantly compared with baseline (0.05 ± 0.7 vs. 0.09 ± 1.2 episodes per patient per week, respectively; P < 0.001). Importantly, no correlation was observed between ventricular arrhythmia incidence and the curve of COVID-19 incidence. No changes were observed regarding atrial fibrillation/atrial tachycardia episodes over time. CONCLUSIONS: An increase in ventricular arrhythmia incidence was observed in the 2 weeks before the lockdown order, at the time of major governmental measures. Ventricular arrhythmia incidence decreased dramatically during the lockdown.
format Online
Article
Text
id pubmed-8141722
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-81417222021-05-24 Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring() Galand, Vincent Hwang, Elliot Gandjbakhch, Estelle Sebag, Frédéric Marijon, Eloi Boveda, Serge Leclercq, Christophe Defaye, Pascal Rosier, Arnaud Martins, Raphaël Pedro Arch Cardiovasc Dis Clinical Research BACKGROUND: The coronavirus disease 2019 (COVID-19) has been a fast-growing worldwide pandemic. AIMS: We aimed to investigate the incidence of cardiac arrhythmias among a large French cohort of implantable cardioverter defibrillator recipients over the first 5 months of 2020. METHODS: Five thousand nine hundred and fifty-four implantable cardioverter defibrillator recipients were followed by remote monitoring during the COVID-19 period (from 01 January to 31 May 2020). Data were obtained from automated remote follow-up of implantable cardioverter defibrillators utilizing the Implicity® platform. For all patients, the type of arrhythmia (atrial fibrillation, ventricular tachycardia or ventricular fibrillation), the number of ventricular arrhythmia episodes and the type of implantable cardioverter defibrillator-delivered therapy were recorded. RESULTS: A total of 472 (7.9%) patients presented 4917 ventricular arrhythmia events. An increase in ventricular arrhythmia incidence was observed after the first COVID-19 case in France, and especially during weeks #10 and #11, at the time of major governmental measures, with an increase in the incidence of antitachycardia pacing delivered therapy. During the 11 weeks before the lockdown order, the curve of the percentage of live-stream television coverage of COVID-19 information matched the ventricular arrhythmia incidence. During the lockdown, the incidence of ventricular arrhythmia decreased significantly compared with baseline (0.05 ± 0.7 vs. 0.09 ± 1.2 episodes per patient per week, respectively; P < 0.001). Importantly, no correlation was observed between ventricular arrhythmia incidence and the curve of COVID-19 incidence. No changes were observed regarding atrial fibrillation/atrial tachycardia episodes over time. CONCLUSIONS: An increase in ventricular arrhythmia incidence was observed in the 2 weeks before the lockdown order, at the time of major governmental measures. Ventricular arrhythmia incidence decreased dramatically during the lockdown. Elsevier Masson SAS. 2021-05 2021-05-24 /pmc/articles/PMC8141722/ /pubmed/34088625 http://dx.doi.org/10.1016/j.acvd.2021.02.005 Text en © 2021 Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Research
Galand, Vincent
Hwang, Elliot
Gandjbakhch, Estelle
Sebag, Frédéric
Marijon, Eloi
Boveda, Serge
Leclercq, Christophe
Defaye, Pascal
Rosier, Arnaud
Martins, Raphaël Pedro
Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
title Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
title_full Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
title_fullStr Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
title_full_unstemmed Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
title_short Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
title_sort impact of covid-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141722/
https://www.ncbi.nlm.nih.gov/pubmed/34088625
http://dx.doi.org/10.1016/j.acvd.2021.02.005
work_keys_str_mv AT galandvincent impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring
AT hwangelliot impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring
AT gandjbakhchestelle impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring
AT sebagfrederic impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring
AT marijoneloi impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring
AT bovedaserge impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring
AT leclercqchristophe impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring
AT defayepascal impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring
AT rosierarnaud impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring
AT martinsraphaelpedro impactofcovid19ontheincidenceofcardiacarrhythmiasinimplantablecardioverterdefibrillatorrecipientsfollowedbyremotemonitoring